SCHEMBL9770892

SCHEMBL9770892

CC(Cc1ccc(C(=O)O)cc1)N1CCOC(c2cccc(Cl)n2)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR1B P47901 3/20 0.38
KDM5A P29375 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
CCR5 P51681 2/20 0.33
CHRM3 P20309 1/20 0.33
ADRB1 P08588 2/20 0.33
ADRB3 P13945 2/20 0.33
DRD4 P21917 1/20 0.33
MCL1 Q07820 2/20 0.33
RORC P51449 1/20 0.33
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
THRB P10828 1/20 0.32
NR4A1 P22736 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9770829 0.86 ADRB2 (0.38) AVPR1BCHRM3ADRB1ADRB3DRD4
SCHEMBL9770863 0.84 ADRB2 (0.39) AVPR1BCHRM3ADRB1ADRB3DRD4
SCHEMBL9770814 0.83 GLA (0.40) AVPR1BCHRM3ADRB1ADRB3DRD4
SCHEMBL9770894 0.82 AVPR1B (0.38) AVPR1BADRB1ADRB3MEN1ALDH1A1
SCHEMBL9770796 0.82 ADRB2 (0.37) AVPR1BADRB1ADRB3DRD4MEN1
SCHEMBL10508328 0.81 MOGAT2 (0.44) CHRM3MEN1KMT2A
SCHEMBL9770835 0.80 SLC2A1 (0.35) AVPR1BADRB1ADRB3DRD4MEN1
SCHEMBL9770964 0.79 SLC5A2 (0.35) AVPR1BDRD4MEN1KMT2ASMN1; SMN2
SCHEMBL9770885 0.78 HRH3 (0.35) DRD4MEN1KMT2AHRH3
SCHEMBL9770815 0.78 HRH3 (0.42) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026702-A Enhances physical performance in animals, effective in lowering blood sugar, reducing body fat and lowering atherogenic lipoproteins DR. KARL THOMAE, GMBH (DE) 1991-06-25 US disclosed
EP-0334146-A1 Morpholines and morpholine-N-oxides, medicines containing these compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1989-09-27 EP disclosed